Early Activation of Th2/Th22 Inflammatory and Pruritogenic Pathways in Acute Canine Atopic Dermatitis Skin Lesions

Journal of Investigative Dermatology

Volumn 136, Issue 10, 2016, Pages 1961-1969

  Olivry, Thierry ^a   Mayhew, David ^b   Paps, Judy S ^a   Linder, Keith E ^a,c   Peredo, Carlos ^d   Rajpal, Deepak ^b   Hofland, Hans ^d,e   Cote Sierra, Javier ^d,f  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b GLAXOSMITHKLINE   (United States)

^c School of Veterinary Medicine   (United States)

^d Stiefel Laboratories Inc   (United States)

^e Dermira Inc   (United States)

^f Sanofi Immunology and Inflammation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CATHEPSIN S; CHYMASE; CLAUDIN 1; CUTANEOUS T CELL ATTRACTING CHEMOKINE; EOTAXIN 2; HISTAMINE METHYLTRANSFERASE; HISTIDINE DECARBOXYLASE; INTERLEUKIN 13; INTERLEUKIN 22; INTERLEUKIN 25; INTERLEUKIN 31; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; LEUKOTRIENE A4 HYDROLASE; LIPOXYGENASE; LIPOXYGENASE 5; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MAST CELL CHYMASE; MASTIN; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 4; NEUROMEDIN B; PROTEINASE; RANTES; THYMIC STROMAL LYMPHOPOIETIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSCRIPTOME; TRYPTASE; UNCLASSIFIED DRUG; CYTOKINE; INTERLEUKIN 9; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; CYTOKINE RELEASE; DERMATOPHAGOIDES FARINAE; DOG DISEASE; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HOUSE DUST ALLERGY; IMMUNE DYSREGULATION; INNATE IMMUNITY; MALE; MICROARRAY ANALYSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PRURITUS; QUANTITATIVE ANALYSIS; SKIN BIOPSY; SKIN SENSITIZATION; TH2 CELL; TH22 CELL; UPREGULATION; ANIMAL; DISEASE MODEL; DOG; GENETICS; IMMUNOLOGY; INFLAMMATION; PATHOLOGY; SKIN; SPECIES DIFFERENCE; TIME FACTOR;

ADAPTIVE IMMUNITY; ANIMALS; CYTOKINES; DERMATITIS, ATOPIC; DERMATOPHAGOIDES FARINAE; DISEASE MODELS, ANIMAL; DOGS; FEMALE; IMMUNITY, INNATE; INFLAMMATION; INTERLEUKIN-9; INTERLEUKINS; MALE; PRURITUS; SKIN; SPECIES SPECIFICITY; TH2 CELLS; TIME FACTORS; UP-REGULATION;

EID: 84996772746     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1016/j.jid.2016.05.117     Document Type: Article

References (72)

1. Andoh, T., Haza, S., Saito, A., Kuraishi, Y., Involvement of leukotriene B4 in spontaneous itch-related behaviour in NC mice with atopic dermatitis-like skin lesions. Exp Dermatol 20 (2011), 894–898.
2. Andoh, T., Kuraishi, Y., Intradermal leukotriene B4, but not prostaglandin E2, induces itch-associated responses in mice. Eur J Pharmacol 353 (1998), 93–96.
3. Andoh, T., Kuwazono, T., Lee, J.B., Kuraishi, Y., Gastrin-releasing peptide induces itch-related responses through mast cell degranulation in mice. Peptides 32 (2011), 2098–2103.
4. Bizikova, P., Pucheu-Haston, C.M., Eisenschenk, M.N., Marsella, R., Nuttall, T., Santoro, D., Review: role of genetics and the environment in the pathogenesis of canine atopic dermatitis. Vet Dermatol, 26, 2015 95–e26.
5. Camp, R.D., Coutts, A.A., Greaves, M.W., Kay, A.B., Walport, M.J., Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4. Br J Pharmacol 80 (1983), 497–502.
6. Carr, M.N., Torres, S.M., Koch, S.N., Reiter, L.V., Investigation of the pruritogenic effects of histamine, serotonin, tryptase, substance P and interleukin-2 in healthy dogs. Vet Dermatol 20 (2009), 105–110.
7. Choy, D.F., Hsu, D.K., Seshasayee, D., Fung, M.A., Modrusan, Z., Martin, F., et al. Comparative transcriptomic analyses of atopic dermatitis and psoriasis reveal shared neutrophilic inflammation. J Allergy Clin Immunol 130 (2012), 1335–1343.e5.
8. Ciprandi, G., De Amici, M., Giunta, V., Marseglia, A., Marseglia, G., Serum interleukin-9 levels are associated with clinical severity in children with atopic dermatitis. Pediatr Dermatol 30 (2013), 222–225.
9. Correa da Rosa, J., Malajian, D., Shemer, A., Rozenblit, M., Dhingra, N., Czarnowicki, T., et al. Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin. J Allergy Clin Immunol 135 (2015), 712–720.
10. Cosgrove, S.B., Wren, J.A., Cleaver, D.M., Walsh, K.F., Follis, S.I., King, V.I., et al. A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel(R)) in client-owned dogs with atopic dermatitis. Vet Dermatol 24 (2013), 587–597 e141–2.
11. Czarnowicki, T., Gonzalez, J., Shemer, A., Malajian, D., Xu, H., Zheng, X., et al. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population. J Allergy Clin Immunol 136 (2015), 104–115.e7.
12. Czarnowicki, T., Krueger, J.G., Guttman-Yassky, E., Skin barrier and immune dysregulation in atopic dermatitis: An evolving story with important clinical implications. J Allergy Clin Immunol Pract 2 (2014), 371–379 quiz 380–1.
13. Dou, Y.C., Hagstromer, L., Emtestam, L., Johansson, O., Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study. Arch Dermatol Res 298 (2006), 31–37.
14. Esaki, H., Ewald, D.A., Ungar, B., Rozenblit, M., Zheng, X., Xu, H., et al. Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection. J Allergy Clin Immunol 135 (2015), 153–163.
15. Eyerich, S., Eyerich, K., Pennino, D., Carbone, T., Nasorri, F., Pallotta, S., et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 119 (2009), 3573–3585.
16. Fornasa, G., Tsilingiri, K., Caprioli, F., Botti, F., Mapelli, M., Meller, S., et al. Dichotomy of short and long thymic stromal lymphopoietin isoforms in inflammatory disorders of the bowel and skin. J Allergy Clin Immunol 136 (2015), 413–422.
17. Gittler, J.K., Krueger, J.G., Guttman-Yassky, E., Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis. J Allergy Clin Immunol 131 (2013), 300–313.
18. Gittler, J.K., Shemer, A., Suarez-Farinas, M., Fuentes-Duculan, J., Gulewicz, K.J., Wang, C.Q., et al. Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol 130 (2012), 1344–1354.
19. Gonzales, A.J., Bowman, J.W., Fici, G.J., Zhang, M., Mann, D.W., Mitton-Fry, M., Oclacitinib (Apoquel) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy. J Vet Pharmacol Ther 37 (2014), 317–324.
20. Gonzales, A.J., Humphrey, W.R., Messamore, J.E., Fleck, T.J., Fici, G.J., Shelly, J.A., et al. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Vet Dermatol 24 (2013), 48–53 e11–2.
21. Hagermark, O., Rajka, G., Bergvist, U., Experimental itch in human skin elicited by rat mast cell chymase. Acta Derm Venereol 52 (1972), 125–128.
22. Hamilton, J.D., Suarez-Farinas, M., Dhingra, N., Cardinale, I., Li, X., Kostic, A., et al. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis. J Allergy Clin Immunol 134 (2014), 1293–1300.
23. Imai, Y., Yasuda, K., Sakaguchi, Y., Haneda, T., Mizutani, H., Yoshimoto, T., et al. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proc Natl Acad Sci USA 110 (2013), 13921–13926.
24. Jassies-van der Lee, A., Rutten, V.P., Bruijn, J., Willemse, T., Broere, F., CD4+ and CD8+ skin-associated T lymphocytes in canine atopic dermatitis produce interleukin-13, interleukin-22 and interferon-gamma and contain a CD25+ FoxP3+ subset. Vet Dermatol, 25, 2014 456–e72.
25. Kietzmann, M., Eicosanoid levels in canine inflammatory skin diseases. von Tscharner, C., Halliwell, R.E.W., (eds.) Advances in veterinary dermatology, 1990, Baillière-Tindall, London, UK, 211–220.
26. Kim, N., Bae, K.B., Kim, M.O., Yu, D.H., Kim, H.J., Yuh, H.S., et al. Overexpression of cathepsin S induces chronic atopic dermatitis in mice. J Invest Dermatol 132 (2012), 1169–1176.
27. Klukowska-Rotzler, J., Chervet, L., Muller, E.J., Roosje, P., Marti, E., Janda, J., Expression of thymic stromal lymphopoietin in canine atopic dermatitis. Vet Dermatol 24 (2013), 54–59 e13–4.
28. Lott, J.M., Sumpter, T.L., Turnquist, H.R., New dog and new tricks: evolving roles for IL-33 in type 2 immunity. J Leukoc Biol 97 (2015), 1037–1048.
29. Ma, L., Xue, H.B., Guan, X.H., Shu, C.M., Zhang, J.H., Yu, J., Possible pathogenic role of T helper type 9 cells and interleukin (IL)-9 in atopic dermatitis. Clin Exp Immunol 175 (2014), 25–31.
30. Maeda, S., Fujiwara, S., Omori, K., Kawano, K., Kurata, K., Masuda, K., et al. Lesional expression of thymus and activation-regulated chemokine in canine atopic dermatitis. Vet Immunol Immunopathol 88 (2002), 79–87.
31. Maeda, S., Tsukui, T., Saze, K., Masuda, K., Ohno, K., Tsujimoto, H., et al. Production of a monoclonal antibody to canine thymus and activation-regulated chemokine (TARC) and detection of TARC in lesional skin of dogs with atopic dermatitis. Vet Immunol Immunopathol 103 (2005), 83–92.
32. Malajian, D., Guttman-Yassky, E., New pathogenic and therapeutic paradigms in atopic dermatitis. Cytokine 73 (2015), 311–318.
33. Marsella, R., Girolomoni, G., Canine models of atopic dermatitis: a useful tool with untapped potential. J Invest Dermatol 129 (2009), 2351–2357.
34. Marsella, R., Olivry, T., Maeda, S., Cellular and cytokine kinetics after epicutaneous allergen challenge (atopy patch testing) with house dust mites in high-IgE beagles. Vet Dermatol 17 (2006), 111–120.
35. Martel, B.C., Litman, T., Hald, A., Norsgaard, H., Lovato, P., Dyring-Andersen, B., et al. Distinct molecular signatures of mild extrinsic and intrinsic atopic dermatitis. Exp Dermatol 25 (2016), 453–459.
36. Michels, G.M., Ramsey, D.S., Mahabir, S., Hoevers, J., Walters, R.R., Martinon, O., et al. Proof-of-concept efficacy and safety study of an anti-interleukin-31 monoclonal antibody for the treatment of atopic dermatitis in client-owned dogs. [abstract] Vet Dermatol, 26, 2015, 138.
37. Mizuno, T., Kanbayashi, S., Okawa, T., Maeda, S., Okuda, M., Molecular cloning of canine interleukin-31 and its expression in various tissues. Vet Immunol Immunopathol 131 (2009), 140–143.
38. Mu, Z., Zhao, Y., Liu, X., Chang, C., Zhang, J., Molecular biology of atopic dermatitis. Clin Rev Allergy Immunol 47 (2014), 193–218.
39. Nemoto, O., Furue, M., Nakagawa, H., Shiramoto, M., Hanada, R., Matsuki, S., et al. The first trial of CIM331, a humanized anti-human IL-31 receptor A antibody, for healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomised, double-blind, placebo-controlled study. Br J Dermatol 174 (2015), 296–304.
40. Nograles, K.E., Zaba, L.C., Shemer, A., Fuentes-Duculan, J., Cardinale, I., Kikuchi, T., et al. IL-22-producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 123 (2009), 1244–1252.e2.
41. Nuttall, T., Knight, P.A., McAleese, S.M., Lamb, J.R., Hill, P.B., Expression of Th1, Th2 and immunosuppressive cytokine gene transcripts in canine atopic dermatitis. Clin Exp Allergy 32 (2002), 789–795.
42. Olivry, T., Dean, G.A., Tompkins, M.B., Dow, J.L., Moore, P.F., Toward a canine model of atopic dermatitis: amplification of cytokine-gene transcripts in the skin of atopic dogs. Exp Dermatol 8 (1999), 204–211.
43. Olivry, T., Deangelo, K.B., Dunston, S.M., Clarke, K.B., McCall, C.A., Patch testing of experimentally sensitized beagle dogs: Development of a model for skin lesions of atopic dermatitis. Vet Dermatol 17 (2006), 95–102.
44. Olivry, T., Foster, A.P., Mueller, R.S., McEwan, N.A., Chesney, C., Williams, H.C., Interventions for atopic dermatitis in dogs: a systematic review of randomized controlled trials. Vet Dermatol 21 (2010), 4–22.
45. Olivry, T., Linder, K.E., Paps, J.S., Bizikova, P., Dunston, S., Donne, N., et al. Validation of a novel epicutaneous delivery system for patch testing of house dust mite-hypersensitive dogs. Vet Dermatol, 23, 2012 525–e106.
46. Olivry, T., Wofford, J., Paps, J.S., Dunston, S.M., Stratum corneum removal facilitates experimental sensitization to allergens in atopic dogs. Vet Dermatol 22 (2011), 188–196.
47. Papoiu, A.D., Wang, H., Nattkemper, L., Tey, H.L., Ishiuji, Y., Chan, Y.H., et al. A study of serum concentrations and dermal levels of NGF in atopic dermatitis and healthy subjects. Neuropeptides 45 (2011), 417–422.
48. Plager, D.A., Torres, S.M., Koch, S.N., Kita, H., Gene transcription abnormalities in canine atopic dermatitis and related human eosinophilic allergic diseases. Vet Immunol Immunopathol 149 (2012), 136–142.
49. Pucheu-Haston, C.M., Bizikova, P., Marsella, R., Santoro, D., Nuttall, T., Eisenschenk, M.N., Review: lymphocytes, cytokines, chemokines and the T-helper 1-T-helper 2 balance in canine atopic dermatitis. Vet Dermatol, 26, 2015 124–e32.
50. Reddy, V.B., Shimada, S.G., Sikand, P., Lamotte, R.H., Lerner, E.A., Cathepsin S elicits itch and signals via protease-activated receptors. J Invest Dermatol 130 (2010), 1468–1470.
51. Reddy, V.B., Sun, S., Azimi, E., Elmariah, S.B., Dong, X., Lerner, E.A., Redefining the concept of protease-activated receptors: Cathepsin S evokes itch via activation of mrgprs. Nat Commun, 6, 2015, 7864.
52. Roggenkamp, D., Falkner, S., Stab, F., Petersen, M., Schmelz, M., Neufang, G., Atopic keratinocytes induce increased neurite outgrowth in a coculture model of porcine dorsal root ganglia neurons and human skin cells. J Invest Dermatol 132 (2012), 1892–1900.
53. Rozenblit, M., Suarez-Farinas, M., Shemer, A., Khattri, S., Gilleaudeau, P., Sullivan-Whalen, M., et al. Residual genomic profile after cyclosporine treatment may offer insights into atopic dermatitis reoccurrence. J Allergy Clin Immunol 134 (2014), 955–957.
54. Rukwied, R.R., Main, M., Weinkauf, B., Schmelz, M., NGF sensitizes nociceptors for cowhage- but not histamine-induced itch in human skin. J Invest Dermatol 133 (2013), 268–270.
55. Ruzicka, T., Simmet, T., Peskar, B.A., Ring, J., Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Invest Dermatol 86 (1986), 105–108.
56. Saaf, A.M., Tengvall-Linder, M., Chang, H.Y., Adler, A.S., Wahlgren, C.F., Scheynius, A., et al. Global expression profiling in atopic eczema reveals reciprocal expression of inflammatory and lipid genes. PLoS One, 3, 2008, e4017.
57. Savinko, T., Karisola, P., Lehtimaki, S., Lappetelainen, A.M., Haapakoski, R., Wolff, H., et al. ST2 regulates allergic airway inflammation and T-cell polarization in epicutaneously sensitized mice. J Invest Dermatol 133 (2013), 2522–2529.
58. Savinko, T., Matikainen, S., Saarialho-Kere, U., Lehto, M., Wang, G., Lehtimaki, S., et al. IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors. J Invest Dermatol 132 (2012), 1392–1400.
59. Schamber, P., Schwab-Richards, R., Bauersachs, S., Mueller, R.S., Gene expression in the skin of dogs sensitized to the house dust mite Dermatophagoides farinae. G3 (Bethesda) 4 (2014), 1787–1795.
60. Schlapbach, C., Gehad, A., Yang, C., Watanabe, R., Guenova, E., Teague, J.E., et al. Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity. Sci Transl Med, 6, 2014, 219ra8.
61. Schlotter, Y.M., Rutten, V.P., Riemers, F.M., Knol, E.F., Willemse, T., Lesional skin in atopic dogs shows a mixed type-1 and type-2 immune responsiveness. Vet Immunol Immunopathol 143 (2011), 20–26.
62. Schonefuss, A., Wendt, W., Schattling, B., Schulten, R., Hoffmann, K., Stuecker, M., et al. Upregulation of cathepsin S in psoriatic keratinocytes. Exp Dermatol 19 (2010), e80–e88.
63. Soumelis, V., Reche, P.A., Kanzler, H., Yuan, W., Edward, G., Homey, B., et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3 (2002), 673–680.
64. Storan, E.R., O'Gorman, S.M., McDonald, I.D., Steinhoff, M., Role of cytokines and chemokines in itch. Handb Exp Pharmacol 226 (2015), 163–176.
65. Suarez-Farinas, M., Dhingra, N., Gittler, J., Shemer, A., Cardinale, I., de Guzman Strong, C., et al. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol 132 (2013), 361–370.
66. Suarez-Farinas, M., Gittler, J.K., Shemer, A., Cardinale, I., Krueger, J.G., Guttman-Yassky, E., Residual genomic signature of atopic dermatitis despite clinical resolution with narrow-band UVB. J Allergy Clin Immunol 131 (2013), 577–579.
67. Suarez-Farinas, M., Tintle, S.J., Shemer, A., Chiricozzi, A., Nograles, K., Cardinale, I., et al. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J Allergy Clin Immunol 127 (2011), 954–964 e1–4.
68. Sukhtankar, D.D., Ko, M.C., Physiological function of gastrin-releasing peptide and neuromedin B receptors in regulating itch scratching behavior in the spinal cord of mice. PLoS One, 8, 2013, e67422.
69. Ui, H., Andoh, T., Lee, J.B., Nojima, H., Kuraishi, Y., Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice. Eur J Pharmacol 530 (2006), 172–178.
70. Wang, A.X., Xu Landen, N., New insights into T cells and their signature cytokines in atopic dermatitis. IUBMB Life 67 (2015), 601–610.
71. Wood, S.H., Clements, D.N., Ollier, W.E., Nuttall, T., McEwan, N.A., Carter, S.D., Gene expression in canine atopic dermatitis and correlation with clinical severity scores. J Dermatol Sci 55 (2009), 27–33.
72. Woodmansee, D.P., Simon, R.A., A pilot study examining the role of zileuton in atopic dermatitis. Ann Allergy Asthma Immunol 83 (1999), 548–552.